Found: 15
Select item for more details and to access through your institution.
Prevalence and management of coronary chronic total occlusions in a tertiary veterans affairs hospital.
- Published in:
- Catheterization & Cardiovascular Interventions, 2014, v. 84, n. 4, p. 637, doi. 10.1002/ccd.25264
- By:
- Publication type:
- Article
The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial.
- Published in:
- Calcified Tissue International, 2010, v. 86, n. 5, p. 343, doi. 10.1007/s00223-010-9352-5
- By:
- Publication type:
- Article
Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function.
- Published in:
- European Heart Journal, 2010, v. 31, n. 18, p. 2262, doi. 10.1093/eurheartj/ehq228
- By:
- Publication type:
- Article
Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus.
- Published in:
- Diabetes & Vascular Disease Research, 2016, v. 13, n. 2, p. 113, doi. 10.1177/1479164115618517
- By:
- Publication type:
- Article
Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?
- Published in:
- Diabetes & Vascular Disease Research, 2014, v. 11, n. 5, p. 343, doi. 10.1177/1479164114540924
- By:
- Publication type:
- Article
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial.
- Published in:
- Diabetes & Vascular Disease Research, 2012, v. 9, n. 2, p. 131, doi. 10.1177/1479164111428628
- By:
- Publication type:
- Article
Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment.
- Published in:
- Diabetes & Vascular Disease Research, 2011, v. 8, n. 2, p. 101, doi. 10.1177/1479164111403334
- By:
- Publication type:
- Article
Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.
- Published in:
- Diabetes & Vascular Disease Research, 2009, v. 6, n. 1, p. 7, doi. 10.3132/dvdr.2009.002
- By:
- Publication type:
- Article
The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale.
- Published in:
- Diabetes & Vascular Disease Research, 2009, v. 6, n. 1, p. 43, doi. 10.3132/dvdr.2009.009
- By:
- Publication type:
- Article
Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK.
- Published in:
- Diabetes & Vascular Disease Research, 2007, v. 4, n. 3, p. 222, doi. 10.3132/dvdr.2007.043
- By:
- Publication type:
- Article
Application of the 'hybrid approach' to chronic total occlusion interventions: a detailed procedural analysis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Application of the ' Hybrid Approach' to Chronic Total Occlusion Interventions: A Detailed Procedural Analysis.
- Published in:
- Journal of Interventional Cardiology, 2014, v. 27, n. 1, p. 36, doi. 10.1111/joic.12083
- By:
- Publication type:
- Article
Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162845
- By:
- Publication type:
- Article
A Randomized Controlled Trial of Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis.
- Published in:
- Journal of Invasive Cardiology, 2020, v. 32, n. 12, p. E305
- By:
- Publication type:
- Article
Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: Insights from a multicenter united states registry.
- Published in:
- Catheterization & Cardiovascular Interventions, 2015, v. 85, n. 3, p. 393, doi. 10.1002/ccd.25359
- By:
- Publication type:
- Article